Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Esa Pekka Sandell"'
Autor:
Detlef Jäger, Olli Takkunen, Ferenc Follath, Hanjörg Just, Susanna Hinkka, Esa Pekka Sandell, Veselin Mitrovic, Keijo Peuhkurinen, Julius Gy. Papp, Lasse Lehtonen
Publikováno v:
The American Journal of Cardiology. 83:21-25
A series of dose-ranging and tolerability studies of intravenous levosimendan (bolus then infusion) were conducted in 40 patients with low-output heart failure (cardiac index 2 per minute). These trials were conducted as preparation for the Levosimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46c86f8d9af94cd4d73ef29199cd4ce6
https://doi.org/10.1016/s0002-9149(99)00314-8
https://doi.org/10.1016/s0002-9149(99)00314-8
Autor:
Esa-Pekka Sandell, Jyrki Lilleberg, Lasse Lehtonen, Vesa Ylönen, Bramah N. Singh, Lauri Toivonen
Publikováno v:
The American Journal of Cardiology. 83:16-20
Levosimendan is a novel inotropic and vasodilating agent that enhances the calcium sensitivity of myofilaments by binding to troponin C. Unlike other calcium sensitizers, it is highly dependent on the intracellular concentration of calcium. As a resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e280dc8e7c4b87c87680e80612cd13b
https://doi.org/10.1016/s0002-9149(99)00313-6
https://doi.org/10.1016/s0002-9149(99)00313-6
Autor:
Esa-Pekka Sandell, Marja Häyhä, Saila Antila, Paula Heikkinen, Pekka Ottoila, Lasse A. Lehtonen, Pertti J. Pentikäinen
Publikováno v:
Journal of Cardiovascular Pharmacology. 26:57-62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fac0ba02552616e16025f018ca683f15
https://doi.org/10.1097/00005344-199506261-00008
https://doi.org/10.1097/00005344-199506261-00008
Autor:
Markku S, Nieminen, Esa-Pekka, Sandell
Publikováno v:
Italian heart journal : official journal of the Italian Federation of Cardiology. 4
Levosimendan is a new vasodilator agent with properties which improve cardiac contractility by calcium sensitization. Its dose-related efficacy and prolonged action have been documented in several major studies both against placebo and dobutamine. Ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::930154e44cf069baa274db0d44d5c71e
https://pubmed.ncbi.nlm.nih.gov/14635369
https://pubmed.ncbi.nlm.nih.gov/14635369
Autor:
Kimmo Luomanmaki, Esa-Pekka Sandell, Matti Kivikko, Saila Antila, Lasse Lehtonen, Pertti J. Pentikäinen, Tapio Aalto
Publikováno v:
Journal of Cardiac Failure. 5:48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cf92ed20fd3c7963208e5b834ef8f20
https://doi.org/10.1016/s1071-9164(99)91522-1
https://doi.org/10.1016/s1071-9164(99)91522-1